General Motors, Abbott Laboratories, and Johnson & Johnson all raised their full-year guidance following strong second-quarter earnings reports. General Motors posted a 14% earnings per share beat on sales of $48.0 billion and lifted its adjusted EBIT, adjusted EPS, and automotive operating cash flow outlook for the second time this year. Abbott Laboratories reported adjusted EPS of $1.31 on $12.6 billion in sales and raised its adjusted EPS guidance to $5.45–$5.60 while reaffirming its comparable sales forecast. Johnson & Johnson beat on both top and bottom lines for the ninth consecutive quarter and increased its sales and adjusted EPS guidance, putting it on track to surpass $100 billion in annual revenue for the first time in its history.
Abbott LaboratoriesBeat Q2 earnings and raised adjusted EPS guidance.
Johnson & JohnsonBeat Q2 earnings and raised sales and adjusted EPS guidance, on track for first $100B revenue year.
General Motors CompanyBeat Q2 earnings and raised full-year adjusted EBIT, EPS, and cash flow outlook.